Real World Assessment of People Living With Chronic Hepatitis B in Australia
NCT ID: NCT04914611
Last Updated: 2024-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2022-02-17
2027-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HBsAg Positive
Patients with chronic hepatitis B infection as defined by HBV surface antigen positive
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. 16 years of age or older.
3. Attended the health service for HBV care within the prior 12 months from study commencement (retrospective recruitment) OR Attending the health service for HBV care from study commencement (prospective recruitment)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kirby Institute
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gail Matthews, PhD MBBS
Role: PRINCIPAL_INVESTIGATOR
Kirby Insitute, UNSW
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)
Sydney, New South Wales, Australia
St Vincent's Hospital
Sydney, New South Wales, Australia
Justice Health and Forensic Mental Health Network
Sydney, New South Wales, Australia
Blacktown Mount Druitt Hospital
Sydney, New South Wales, Australia
Westmead Hospital
Sydney, New South Wales, Australia
Menzies School of Health Research (Royal Darwin & Alice Springs Hospitals)
Darwin, Northern Territory, Australia
Top End Medical Centre
Darwin, Northern Territory, Australia
Sunshine Coast University Hospital
Birtinya, Queensland, Australia
Cairns and Hinterland Hospital Health Service
Cairns, Queensland, Australia
Torres and Cape Hospital and Health Service
Cairns, Queensland, Australia
Central Adelaide Local Health Network (Royal Adelaide & The Queen Elizabeth Hospitals)
Adelaide, South Australia, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Cohealth
Melbourne, Victoria, Australia
Utopia Refugee and Asylum Seeker Health
Melbourne, Victoria, Australia
Royal Melbourne Hospital
Melbourne, Victoria, Australia
St Vincent's Hospital
Melbourne, Victoria, Australia
Albany Health Campus, WACHS Great Southern
Albany, Western Australia, Australia
Broome Regional Hospital, WACHS Kimberley
Broome, Western Australia, Australia
Kalgoorlie Health Campus, WACHS Goldfields
Kalgoorlie-Boulder, Western Australia, Australia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gregory J Dore, MBBS, PhD
Role: primary
Rebecca J Hickey
Role: backup
Tracey Brown
Role: primary
Tasnim Hasan
Role: primary
Kindness Bondezi
Role: primary
Paula Binks
Role: primary
Amanda Carey
Role: primary
Elen Witness
Role: primary
Sharna Radlof
Role: primary
Sharna Radlof
Role: primary
Catherine Ferguson
Role: primary
Jeffrey Stewart
Role: backup
Janine Roney
Role: primary
Nicole Allard
Role: primary
Peita Pittella
Role: primary
Roisin McColl
Role: primary
Heeba Doughan
Role: primary
Lloyd Nash
Role: primary
Leonie Davidson
Role: primary
Georgina Trotter
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VHCRP2008
Identifier Type: -
Identifier Source: org_study_id